Estudo de coorte | Análise de diagnósticos neuropsiquiátricos após início do uso de montelucaste.

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation – JAMA Network Open

Conteúdos relacionados:

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis – U.S. Food & Drug Administration

Adverse drug reactions of montelukast in children and adults – Pharmacology Research & Perspectives

Comentário no Twitter

This cohort study of patients with asthma or allergic rhinitis found montelukast use is associated with higher odds of neuropsychiatric outcomes, including anxiety and insomnia. https://t.co/HAzcADsHZc

— JAMA Network Open (@JAMANetworkOpen) May 24, 2022